245 related articles for article (PubMed ID: 27313329)
21. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
[TBL] [Abstract][Full Text] [Related]
22. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
23. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
24. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.
Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Snavely J; Chen H; Savani BN; Kassim A; Greer JP; Schuening FG; Engelhardt BG; Jagasia MH
Blood; 2011 Jul; 118(4):1140-4. PubMed ID: 21628416
[TBL] [Abstract][Full Text] [Related]
26. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant.
Metafuni E; Giammarco S; Bellesi S; Rossi M; Minnella G; Limongiello MA; Valentini CG; Teofili L; Sica S; Chiusolo P
Int J Lab Hematol; 2023 Dec; 45(6):935-944. PubMed ID: 37646104
[TBL] [Abstract][Full Text] [Related]
27. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
28. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.
Lin MT; Storer B; Martin PJ; Tseng LH; Gooley T; Chen PJ; Hansen JA
N Engl J Med; 2003 Dec; 349(23):2201-10. PubMed ID: 14657427
[TBL] [Abstract][Full Text] [Related]
29. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
30. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.
Sato-Otsubo A; Nannya Y; Kashiwase K; Onizuka M; Azuma F; Akatsuka Y; Ogino Y; Satake M; Sanada M; Chiba S; Saji H; Inoko H; Kennedy GC; Yamamoto K; Morishima S; Morishima Y; Kodera Y; Sasazuki T; Ogawa S;
Blood; 2015 Dec; 126(25):2752-63. PubMed ID: 26432889
[TBL] [Abstract][Full Text] [Related]
32. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
33. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
[TBL] [Abstract][Full Text] [Related]
34. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
Carapito R; Jung N; Kwemou M; Untrau M; Michel S; Pichot A; Giacometti G; Macquin C; Ilias W; Morlon A; Kotova I; Apostolova P; Schmitt-Graeff A; Cesbron A; Gagne K; Oudshoorn M; van der Holt B; Labalette M; Spierings E; Picard C; Loiseau P; Tamouza R; Toubert A; Parissiadis A; Dubois V; Lafarge X; Maumy-Bertrand M; Bertrand F; Vago L; Ciceri F; Paillard C; Querol S; Sierra J; Fleischhauer K; Nagler A; Labopin M; Inoko H; von dem Borne PA; Kuball J; Ota M; Katsuyama Y; Michallet M; Lioure B; Peffault de Latour R; Blaise D; Cornelissen JJ; Yakoub-Agha I; Claas F; Moreau P; Milpied N; Charron D; Mohty M; Zeiser R; Socié G; Bahram S
Blood; 2016 Oct; 128(15):1979-1986. PubMed ID: 27549307
[TBL] [Abstract][Full Text] [Related]
35. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
36. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
Cho HJ; Shin DY; Kim JH; Bae JY; Lee KH; See CJ; Kim N; Park EK; Ra EK; Lee JE; Hong YC; Kim HK; Park SS; Yoon SS; Lee DS; Han KS; Park MH; Park S; Kim BK; Kim I
Clin Transplant; 2012; 26(3):476-83. PubMed ID: 22035017
[TBL] [Abstract][Full Text] [Related]
37. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
38. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Socié G; Loiseau P; Tamouza R; Janin A; Busson M; Gluckman E; Charron D
Transplantation; 2001 Aug; 72(4):699-706. PubMed ID: 11544434
[TBL] [Abstract][Full Text] [Related]
39. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
[TBL] [Abstract][Full Text] [Related]
40. Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation.
Hosokai R; Masuko M; Shibasaki Y; Saitoh A; Furukawa T; Imai C
Biol Blood Marrow Transplant; 2017 Apr; 23(4):606-611. PubMed ID: 28042021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]